Atlas Trials

Safety, Blood Levels and Effects of MGB-BP-3

Clinical trial NCT02518607 · COMPLETED

Trial details

NCT number
NCT02518607
Sponsor
MGB Biopharma Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2015-07-01
Primary completion
2015-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.